Table 6.
Proteins | PDB ID | Bargapten | Psoralene | Psoralenoside | Germanicol acetate | Standard drugs | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
π-π bonds | Amino Acids | π-π bonds | Amino Acids | π-π bonds | Amino Acids | π-π bonds | Amino Acids | π-π bonds | Amino Acids | ||
Adrenergic α1 | 3538 | 2 |
TRP 295 PHE 299 |
1 |
PHE 299 CYS 181 |
1 | VAL 168 | 0 | – | 3A |
PHE 299 TRP 295 PHE 298 |
Muscranic M1 | 5CXV | 2 |
TYR 381 TYR 106 |
3 |
TYR 404 TRP 378 CYS 407 |
2 |
ALA 363 LYS 362 |
0 | – | 1B | TYR 404 |
Muscranic M3 | 4 U14 | 1 | TYR 506 | 1 | TRP 503 | 1 | TYR 1018 | 0 | – | 0C | – |
Dopaminergic D2 | 6CM4 | 4 |
TRP 386 PHE 386 PHE 390 ASP 114 |
4 |
PHE 390 TRP 386 PHE 198 PHE 389 |
2 |
THR 412 TRP 100 |
1 | TYR 408 | 4D |
ASP 114 PHE 389 LEU 94 TRP 100 |
Calmodulin | 1CTR | 2 |
MET 124 PHE 92 |
1 | LEU 105 | 2 |
GLU 11 MET 72 |
0 | – | 5E |
MET 144 MET 145 MET 109 LEU 105 PHE 92 |
Calcium channel | 1T3S | 3 |
LEU 86 GLU 87 |
2 |
ARG 65 GLU 87 |
0 | – | 0 | – | 1F | ARG 413 |
Histaminergic H1 | 3RZE | 2 |
ARG 97 CYS 180 |
2 |
ARG 97 CYS 180 |
0 | – | 0 | – | 2G |
PHE 1104 GLU 1011 |
H+/K+ ATPase | 5YLU | 1 | PHE 909 | 1 | GLY 611 | 1 | ASP 443 | 0 | – | 1H | ARG 544 |
Histaminergic H2 | P25021 | 2 |
PHE 249 PHE 171 |
3 |
PHE 171 PHE 249 VAL 92 |
1 | PHE 171 | 0 | – | 2I |
PHE 267 VAL 268 |
Mu Opioid | 5C1M | 3 |
VAL 300 MET 151 TRP 293 |
3 |
TYR 494 CYS 407 TRP 378 |
2 |
THR 1142 ARG 1145 |
1 | PHE 239 | 3J |
ILE 296 HIS 297 TRP 293 |
Standard inhibitors or activators are: (A) phenoxy benzamine, (B) piranzapine, (C) atropine, (D) domperidone, (E) calmozolium, (F) verapamil, (G) pyrilimine, (H) omeprazole, (I) ranitidine and (J) loperamide. Amino acids are: ALA, alanine; GLN, glutamine; GLY, glycine; HIS, histidine; LYS, lysine; PHE, phenylalanine; SER, Serine; TRP, tryptophan and TYR, tyrosine and VAL, valine